Product Information
APREPITANT 40 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $45.3881 per EA under NDC 68462058385. Its NADAC has been published 427 times since Jun 20, 2018.
FDA first approved this application on Oct 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462058385
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA207777FDA Approved
10/12/2017
TE Code
AB
On Market Since
10/12/2017
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 40 MG CAPSULE has been published 427 times since Jun 20, 2018, and over the history we have for it it has declined 40.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $45.3881 per EA |
|---|---|
| All-time high | $83.7756 (Aug 12, 2020) |
| All-time low | $34.4783 (Nov 20, 2024) |
| 52-week high | $47.5661 |
| 52-week low | $38.1856 |
| Median price | $64.6422 |
| Average price | $63.1795 |
| Largest weekly change | +42.7% (Feb 22, 2023) |
| Weeks tracked | 427 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of APREPITANT 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 40 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $45.3881 per EA (NDC 68462058385), effective Aug 19, 2026.
How has the price of APREPITANT 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 40 MG CAPSULE has declined 40.2%. It has been tracked across 427 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for APREPITANT 40 MG CAPSULE?
Since Jun 20, 2018, the NADAC for APREPITANT 40 MG CAPSULE has ranged from a low of $34.4783 (Nov 20, 2024) to a high of $83.7756 (Aug 12, 2020), with a median of $64.6422 per EA.
Are there cheaper alternatives to APREPITANT 40 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as APREPITANT 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures APREPITANT 40 MG CAPSULE?
APREPITANT 40 MG CAPSULE (NDC 68462058385) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.